The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.

Journal of drugs in dermatology : JDD

Volumn 2, Issue 3, 2003, Pages 260-266

  Gottlieb, Alice B ^a   Chaudhari, Umesh ^a   Baker, Daniel G ^a   Perate, Michelle ^a   Dooley, Lisa T ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HOSPITALIZATION; HUMAN; MIDDLE AGED; NON PROFIT ORGANIZATION; NONPARAMETRIC TEST; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PHYSICIAN; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; STANDARD; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; DOUBLE-BLIND METHOD; FOUNDATIONS; HUMANS; MIDDLE AGED; PHYSICIANS; PSORIASIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 0041743096     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)